• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

Donitriptan hydrochloride

CAS No. 170911-68-9

Donitriptan hydrochloride ( Donitriptan monohydrochloride; Donitriptan HCl )

产品货号. M27447 CAS No. 170911-68-9

Donitriptan hydrochloride is a potent, high efficacy agonist of 5-HT1B/1D receptors with pKis of 9.4 and 9.3, respectively.

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
2MG ¥470 有现货
5MG ¥608 有现货
10MG ¥786 有现货
25MG ¥1855 有现货
50MG ¥3410 有现货
100MG ¥4828 有现货
200MG ¥6253 有现货
500MG ¥9639 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    Donitriptan hydrochloride
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    Donitriptan hydrochloride is a potent, high efficacy agonist of 5-HT1B/1D receptors with pKis of 9.4 and 9.3, respectively.
  • 产品描述
    Donitriptan hydrochloride is a potent, high efficacy agonist of 5-HT1B/1D receptors with pKis of 9.4 and 9.3, respectively.
  • 同义词
    Donitriptan monohydrochloride; Donitriptan HCl
  • 通路
    Endocrinology/Hormones
  • 靶点
    5-HT Receptor
  • 受体
    TRPA1
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    170911-68-9
  • 分子量
    439.9
  • 分子式
    C23H26ClN5O2
  • 纯度
    >98% (HPLC)
  • 溶解度
    ——
  • SMILES
    Cl.N#CC1=CC=C(C=C1)N2CCN(C(=O)COC=3C=CC=4NC=C(C4C3)CCN)CC2
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1.Singh S, et al. Discovery and development of dimeric podocarpic acid leads as potent agonists of liver X receptor with HDL cholesterol raising activity in mice and hamsters. Bioorg Med Chem Lett. 2005 Jun 2;15(11):2824-8.
产品手册
关联产品
  • Dexchlorpheniramine ...

    Dexchlorpheniramine (trade name Polaramine) is an antihistamine with anticholinergic properties used to treat allergic conditions such as hay fever or urticaria.

  • Lurasidone hydrochlo...

    Lurasidone is an atypical antipsychotic developed by Dainippon Sumitomo Pharma.

  • Cerlapirdine

    Cerlapirdine is a selective, potent, full antagonist of the 5-hydroxytryptamine 6 (5-HT6) receptor. Cerlapirdine is already in clinical development for the treatment of cognitive disorders related to Alzheimer's disease and schizophrenia. It works by acting as a selective 5-HT6 receptor antagonist.